Biohit’s strategy 2017–2022
Our mission is “Innovating for Health“.
To be the world’s leading biotechnology company in our chosen markets of digestive tract. Our chosen synergistic markets for unmet need are:
a) advanced, innovative in vitro diagnostics related to digestive tract, and use of these tests in screening
b) products that bind acetaldehyde in the gastrointestinal tract
Regional priority of business development
- EU, Russia, Middle East
Simplification & Operational Efficiency
Supply chain as a competitive advantage: responsive, agile and cost efficient. Create a highly efficient process, together with continuous improvement and digitalisation, with high level of automation of operations.
Continuous improvement: More preventive actions rather than corrective actions.
In every Biohit decision we have to consider this: “What’s in it for the customer? How does it enable innovation on behalf of the customer?”